乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Primary Care >

Type 1 Diabetes

News, opinions and meeting coverage in primary care.

<乌鸦传媒>Automated Glucagon System Linked to Reduced Hypoglycemia

System acted as an effective counterbalance to slower insulin intake

<乌鸦传媒>Opinion Makers: What's the Deal With Blinded CGM Readings?

Steven Edelman, MD, on letting patients see their glucose numbers

<乌鸦传媒>Why Did Afrezza Flop?

Patients don't hate needles that much, docs suggest

<乌鸦传媒>Judge: Medicare Must Cover CGM for T1D Patient

Courts may be forcing CMS' hand for coverage of continuous glucose monitors

<乌鸦传媒>Novo Nordisk Gives Up on Victoza in T1D

Lackluster results for liraglutide as adjunct to insulin therapy

<乌鸦传媒>T1D Patients Face Nearly Double Risk for Dementia

Findings still significant after controlling for vascular risk factors.

<乌鸦传媒>Diabetic Seniors Lobby for Medicare to Cover CGM Devices

Senate panel highlights glucose control issues facing Medicare patients with diabetes.

<乌鸦传媒>ADA: Glucagon Nasal Powder Effective for Kids

Device that shoots powder up nose safe and effective, finds study.

<乌鸦传媒>Three Diabetes Drugs Linked to Ketoacidosis, FDA Warns

FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.

<乌鸦传媒>Slippery Slope: Diet Drugs No Help for Heart

In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 乌鸦传媒 and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.

<乌鸦传媒>Endo Apps: The DIY Artificial Pancreas

Type 1 diabetics and their parents find solutions for closed-loop control.

<乌鸦传媒>Morning Break: Penis Reduction? Patient Suffering

Health news and commentary from around the Web, gathered by the 乌鸦传媒 staff.

<乌鸦传媒>New Treatments for High Potassium on the Horizon

But ultimate success is far from guaranteed.

<乌鸦传媒>Review: Telcare Glucose Meter

An easy-to-use glucose monitor uploads data to the cloud for ready access.